Arizona Nanotechnology Cluster Symposium

The 3rd Annual Arizona Nanotechnology Cluster Symposium

The Symposium will be held on Thursday, April 10, 2008 at the Scottsdale Community College Performing Arts Center, 9000 E Chaparral Rd, Scottsdale, AZ 85256. This will be an all day event with participation from local, national and international organizations. The theme for this year's event is "Small is Big: Global Perspectives on Nanotechnology". Local, National and International speakers to participate. We will also be awarding scholarships to middle school, high school and college students for furthering pursuits in nanotechnology.

Additionally on Friday, April 11 all participants are invited to a luncheon for the French Delegation Minalogic from Grenoble, France from 11 am- 1pm at the Tempe Center for the Arts, 700 W. Rio Salado Parkway, Tempe, AZ, 85281.

Speakers
Key Note Speaker: Brad Buswell, Deputy Under Secretary for Science and Technology, Department of Homeland Security

Speakers:
Dr. Stefan Zollner, Freescale Semiconductor, USA
Dr. Lerwen Liu, Zyvex, Singapore
Dr. Alain C. Diebold, Albany Nanotech, USA
Dr. Steve Goodnick, Arizona State University, USA
Dr. Narbeh Derhacobian, Adesto Technologies, USA
Dr. Papu Maniar, Motorola, USA
Nicolas Leterrier, Minalogic, Grenoble,France
Dr. Hao Yan, Arizona State University, USA
Dr. James Kolodzey, University of Delaware, USA
Dr. Debbie Stokes, FEI, Netherlands
Dr. Normand Voyer, Director, Laval University, Canada
Dr. Steffi Friedrichs, UK Nanotechnology Industries Association, UK
Dr. Max Lu, University of Queensland, Australia
Dr. Tom Picraux, CINT Los Alamos Labs, USA
Dr. Peter Mascher, McMaster University, Ontario, Canada

Panel Discussion: SBIR Funding Opportunities.
Moderator Brett Johnson Snell & Wilmer, Phoenix, AZ
Panelist:
John Waszczak, Raytheon, Tucson, AZ
Dr. John Lombardi, Ventana Research, Tucson, AZ
Dr. Matt Kim, QuantTera, Phoenix, AZ
Grant Anderson, Paragon Spaced Development Corp., Tucson, AZ

To Register please click on the link:
https://www.acteva.com/go/AZNANOTECH

The registration includes all the symposium materials, breakfast, lunch and evening reception.

Genome-wide Study Links Metabolic Changes With Early Onset of Alzheimer’s

Genome-wide Study Links Metabolic Changes With Early Onset of Alzheimer’s
March 14 , 2008 by Editor
PHOENIX, AZ - Researchers at the Translational Genomics Research Institute (TGen) and their colleagues today report a finding that correlates significant under-expression of genes in certain brain regions with the pattern of metabolic deficits in the brains of individuals with Alzheimer’s. The findings provide new information surrounding the development of Alzheimer's disease and identify novel targets to consider when developing methods to diagnose and treat the disease. The results appear on-line in the Early Edition of the Proceedings of the National Academy of Sciences.

Alzheimer's disease is an irreversible, progressive disorder in which certain brain cells (called neurons) deteriorate, resulting in the loss of cognitive functions including memory, judgment and reasoning, movement coordination, and pattern recognition. In advanced stages of the disease, all memory and mental functioning may be lost. The progressive neurological disorder afflicts an estimated five million Americans, a number expected to triple by 2050.



more here: Genome-wide Study Links Metabolic Changes With Early Onset of Alzheimer’s


Bill Austin bill@azhttp.com http://www.azhttp.com/
Vice President of Business Development, AZhttp, Inc.
LinkedIn Profile: http://www.linkedin.com/in/billaustin

Biotech News
AZhttp, Inc.
Biotechnology Marketing

Sourcing and Negotiating Deals with Big BioPharma

Sourcing and Negotiating Deals with Big BioPharma

A Panel & Networking Reception

Thursday March 20, 2008 @ the BioCenter

Agenda
3-3:30PM Networking, Registration, and Tour 3:30-5PM Panel 5-6:30PM St Patrick Networking Reception
From alliance to funding, Big Pharma and established biotech companies are increasingly investing in emerging companies. This Panel brings together executives from these larger companies to identify the type of deals now available to smaller companies, how to secure them, and how to manage them. Questions that will be raised include:• What are the best approaches for identifying a good partner?• What type of partnerships are commonly used? And is your company a best candidate for a simple license, or a full blown joint venture, or a M&A?• What about the rising of Big Pharma VC Funds?• What are the strategies for attracting, securing and structuring strategic investments?• How the Larger Bio-Companies’ needs differ from VCs’ needs?• What are the key contract terms to be negotiated?• What are the strategic reasoning behind different kinds partnerships?• Effects on existing and potential future collaboration partners and other strategic decisions.• Pros and cons of a small company partnering with a larger company.• “Dos” and “don’ts” of managing these important relationships

Speakers
• S. Edward Torres, Managing Director, Lilly Ventures
• Suzy Jones, Senior Director, Business Development, Genentech, Inc. • Sara M. Hall, Founder, Director & Chief Executive Officer, Tacere Therapeutics, Inc. • Mohan Iyer, Managing Director, Merchant Banking, Burrill & Company • David Summa, President & CEO, Acumen Pharmaceuticals • Lead Facilitator: Scott M. Iyama, Corporate Lawyer, Emerging Companies Group Member, Orrick, Herrington & Sutcliffe LLP

Click here for speakers' bios and to read more about this event. Cost & Registration Pre-register at http://www.acteva.com/booking.cfm?bevaid=151902
• Regular Price: $60• Partners' Network: $40• BioCenter Members: Free• On-site Registration: add $10 to the above (if space allows),

Biotech News
AZhttp, Inc.
Biotechnology Marketing

Global Biotechnology Markets Trends Report

Biotech News
AZhttp, Inc.
Biotechnology Marketing

Global Biotechnology Markets Trends Report
"Global Biotechnology Markets Trends," a new research report published by Pharma-Reports.com, is an in-depth analysis of the cutting-edge developments in the global biotechnology markets.

Phoenix, AZ (PRWEB) February 21, 2008 -- "Global Biotechnology Markets Trends," a new research report published by Pharma-Reports.com, is an in-depth analysis of the cutting-edge developments in the global biotechnology markets:
http://pharma-reports.com/shop/item.asp?itemid=13&affillink=EPRW20080222

The report highlights the use of microorganisms, genetics, and biotech processes to create new and hi-tech methods to help developing countries prosper. Process descriptions, requirements, economics, challenges, regulatory frameworks, etc., are covered. The report examines the development of biotechnology in the developing regions of Africa, Asia, and Latin America. It also looks at what governments in these regions are doing to help the growth of this industry.

Various industrial uses of biotechnology are included in this report, with detailed description on how these processes can benefit countries and people in general. One such example is how to utilize the benefits of biotechnology to a waste management system. Many such innovative applications are included in this report, along with many more emerging trends in the biotechnology markets of the world today.

Other Topics covered in this report include:
Growing Importance of Therapeutic Proteins' Market in Biotechnology
Social and Economic Issues Facing the Development of Biotechnology
Recent Trends in Biotech R&D and Commercialization

Details on this report can be found at
http://pharma-reports.com/shop/item.asp?itemid=13&affillink=EPRW20080222

About the Publisher: "Global Biotechnology Markets Trends" is published by Pharma-Reports (www.Pharma-Reports.com), a pharmaceutical and biotechnology industry think tank and leading source for pharmaceutical and biotechnology industry information and research products. Details on all reports can be found at http://pharma-reports.com